189 related articles for article (PubMed ID: 15781379)
1. Immunogenomics of hematopoietic stem cell transplantation.
Charron D
Pathol Biol (Paris); 2005 Apr; 53(3):171-3. PubMed ID: 15781379
[TBL] [Abstract][Full Text] [Related]
2. Immunogenomics of hematopoïetic stem cell transplantation.
Charron D
Transfus Clin Biol; 2003 Jun; 10(3):156-8. PubMed ID: 12798849
[TBL] [Abstract][Full Text] [Related]
3. Non-HLA immunogenetics in hematopoietic stem cell transplantation.
Dickinson AM; Charron D
Curr Opin Immunol; 2005 Oct; 17(5):517-25. PubMed ID: 16085403
[TBL] [Abstract][Full Text] [Related]
4. Identification of MHC II-restricted minor histocompatibility antigens after HLA-identical stem-cell transplantation.
Milosevic S; Bachnick B; Karim K; Bornkamm GW; Witter K; Gerbitz A; Mautner J; Behrends U
Transplantation; 2010 Nov; 90(9):1030-5. PubMed ID: 20802400
[TBL] [Abstract][Full Text] [Related]
5. Analysis of immunodominance among minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation.
Mori S; El-Baki H; Mullen CA
Bone Marrow Transplant; 2003 May; 31(10):865-75. PubMed ID: 12748663
[TBL] [Abstract][Full Text] [Related]
6. Haematopoietic stem cell transplantation: can our genes predict clinical outcome?
Dickinson AM; Harrold JL; Cullup H
Expert Rev Mol Med; 2007 Nov; 9(29):1-19. PubMed ID: 17976248
[TBL] [Abstract][Full Text] [Related]
7. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
[TBL] [Abstract][Full Text] [Related]
8. Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients.
La Nasa G; Littera R; Locatelli F; Giardini C; Ventrella A; Mulargia M; Vacca A; Orrù N; Orrù S; Piras E; Giustolisi G; Lisini D; Nesci S; Caocci G; Carcassi C
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1358-68. PubMed ID: 17950922
[TBL] [Abstract][Full Text] [Related]
9. Role of HLA in hematopoietic SCT.
Nowak J
Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S71-6. PubMed ID: 18978750
[TBL] [Abstract][Full Text] [Related]
10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of HLA-E*0103 homozygosity on survival after allogeneic hematopoietic stem-cell transplantation.
Danzer M; Polin H; Pröll J; Haunschmid R; Hofer K; Stabentheiner S; Hackl C; Kasparu H; König J; Hauser H; Binder M; Weiss R; Gabriel C; Krieger O
Transplantation; 2009 Aug; 88(4):528-32. PubMed ID: 19696636
[TBL] [Abstract][Full Text] [Related]
12. My approach to the immunogenetics of haematopoietic stem cell transplant matching.
Sage D
J Clin Pathol; 2010 Mar; 63(3):194-8. PubMed ID: 20203219
[TBL] [Abstract][Full Text] [Related]
13. An approach to predicting hematopoietic stem cell transplantation outcome using HLA-mismatch information mapped on protein structure data.
Dudkiewicz M; Malanowski P; Czerwin Ski J; Pawłowski K
Biol Blood Marrow Transplant; 2009 Sep; 15(9):1014-25. PubMed ID: 19660714
[TBL] [Abstract][Full Text] [Related]
14. [Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].
Dou LP; DA WM; Zhao DD; Wang C; Lu XC; Kang HY; Yan P; Wang FF; Zhu HY; Li HH; Gao CJ; Yu L
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3111-4. PubMed ID: 18269867
[TBL] [Abstract][Full Text] [Related]
15. Beyond the HLA typing age: genetic polymorphisms predicting transplant outcome.
Dickinson AM; Middleton PG
Blood Rev; 2005 Nov; 19(6):333-40. PubMed ID: 15946779
[TBL] [Abstract][Full Text] [Related]
16. Domestic and foreign donor candidates result in differential probability of matching minor histocompatibility antigens--relevance of selection for hematopoietic stem cell transplantation.
Turpeinen H; Volin L; Partanen J
Tissue Antigens; 2009 Mar; 73(3):236-41. PubMed ID: 19254253
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic stem cell recipients do not develop post-transplantation immune tolerance to antigens present on minimal residual disease.
Natzke AM; Shaw JL; McKeller MR; Emo KL; Mullen CA
Biol Blood Marrow Transplant; 2007 Jan; 13(1):34-45. PubMed ID: 17222751
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic MHC gene transfer enhances antitumor activity of allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease.
Ohashi M; Kobayashi A; Hara H; Miura Y; Yoshida K; Kushida M; Ikarashi Y; Mandai M; Kitajima M; Yoshida T; Aoki K
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2208-15. PubMed ID: 16609036
[TBL] [Abstract][Full Text] [Related]
19. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.
Teshima T; Matsuo K; Matsue K; Kawano F; Taniguchi S; Hara M; Hatanaka K; Tanimoto M; Harada M; Nakao S; Abe Y; Wake A; Eto T; Takemoto Y; Imamura M; Takahashi S; Ishida Y; Kanda Y; Kasai M; Takaue Y
Br J Haematol; 2005 Aug; 130(4):575-87. PubMed ID: 16098073
[TBL] [Abstract][Full Text] [Related]
20. Possible involvement of allogeneic antigens recognised by donor-derived CD4 cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy.
Matsushita M; Yamazaki R; Ikeda H; Mori T; Sumimoto H; Fujita T; Okamoto S; Ikeda Y; Kawakami Y
Br J Haematol; 2006 Jan; 132(1):56-65. PubMed ID: 16371020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
